Fatty Acids, Monounsaturated

• 

  Subject Areas on Research

  • A new helper phospholipid for gene delivery. 
  • Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices. 
  • CPAG: software for leveraging pleiotropy in GWAS to reveal similarity between human traits links plasma fatty acids and intestinal inflammation. 
  • CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. 
  • Charge-reversal amphiphiles for gene delivery. 
  • Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. 
  • Fluvastatin downregulates VEGF-A expression in TNF-α-induced retinal vessel tortuosity. 
  • Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. 
  • Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. 
  • Implausibility of the vibrational theory of olfaction. 
  • Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant. 
  • Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. 
  • One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. 
  • Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. 
  • Quantifying ceramide kinetics in vivo using stable isotope tracers and LC-MS/MS. 
  • Serum and synovial fluid lipidomic profiles predict obesity-associated osteoarthritis, synovitis, and wound repair. 
  • Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery. 
  • The influence of statin medications on prostate-specific antigen levels. 
  • Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis.